Evidence map›Paper›PMID 36376272›Full record

ArticleBone research2022

Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss.

Chen Kan, Jiazhao Yang, Haitao Fan, Yuanjuan Dai, Xingxing Wang, Rui Chen, Jia Liu, Xiangyue Meng, Wei Wang, Guiling Li and 8 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Chen Kan *Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.ORCID http://orcid.org/0000-0003-1205-7410
Jiazhao Yang *Department of Orthopaedics, The First Affiliated Hospital of USTC, Hefei, China.
Haitao Fan *Department of Orthopaedics, Fuyang Hospital of Anhui Medical University, Fuyang, China.
Yuanjuan DaiDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Xingxing WangDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Rui ChenDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Jia LiuDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Xiangyue MengDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Wei WangDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Guiling LiDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Jiao ZhouDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Ya ZhangDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Wanbo ZhuDepartment of Orthopaedics, The First Affiliated Hospital of USTC, Hefei, China.
Shiyuan FangDepartment of Orthopaedics, The First Affiliated Hospital of USTC, Hefei, China.
Haiming WeiDepartment of Hematology, The First Affiliated Hospital of USTC, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Hong ZhengDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. zhenghong@ahmu.edu.cn.ORCID http://orcid.org/0000-0002-4048-6530
Siying WangDepartment of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. sywang@ahmu.edu.cn.
Fang NiDepartment of Hematology, The First Affiliated Hospital of USTC, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. fangni@ustc.edu.cn.ORCID http://orcid.org/0000-0003-3680-8856
Anhui Medical University · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36376272
PMCPMC9663427
OpenAlexW4309087110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.